2-Bromo-5-bromomethylpyridine → 5-(4-Cyanobenzyl)-1-(2-bromopyrid-5-ylmethyl)imidazole
반응식
C([N:20]1[CH:24]=[C:23]([CH2:25][C:26]2[CH:31]=[CH:30][C:29]([C:32]#[N:33])=[CH:28][CH:27]=2)[N:22]=[CH:21]1)(C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.[Br:34][C:35]1[CH:40]=[CH:39][C:38]([CH2:41]Br)=[CH:37][N:36]=1>CN(C=O)C>[C:32]([C:29]1[CH:28]=[CH:27][C:26]([CH2:25][C:23]2[N:22]([CH2:41][C:38]3[CH:39]=[CH:40][C:35]([Br:34])=[N:36][CH:37]=3)[CH:21]=[N:20][CH:24]=2)=[CH:31][CH:30]=1)#[N:33]참가 물질
4
반응 조건
- 온도
- 100 °C
실험 절차
To a flask was charged 1-trityl -4-p-cyanobenzyl imidazole (2.77 mmol, 1.18 g) from Step 1 and 2-bromo-5-bromomethyl pyridine (2.77 mmol, 0.67 g) from Step 2 in DMF (10 mL) and the mixture heated at 100° C. for 6 hr. The DMF was then removed in vacuo and the residue was triturated with ethyl ether. The ethyl ether was then decanted off and replaced with methanol (20 mL). This solution was then refluxed for 4 hr, cooled to ambient temperature and purified on a C18 preperative hplc column to provide the title compound. High resolution FAB-MS: calc; 353.040183 found; 353.040183. 1H-NMR (CD3OD): 4.2 ppm (s, 2H); 5.4 ppm (s, 2H); 7.2 and 7.6 ppm (d, 2H); 8.1 ppm (s, 1H); 9.1 ppm (s, 1H).
후처리
- customThe DMF was then removed in vacuo
- customthe residue was triturated with ethyl ether
- customThe ethyl ether was then decanted off
- temperatureThis solution was then refluxed for 4 hr
- temperaturecooled to ambient temperature
- custompurified on a C18 preperative hplc column
출처 및 근거
- ORD 기록
- ord-97e920e5ef3f44a5afc1d1811b1613ca
- 출처 데이터셋
- uspto-grants-2000_10
- 특허 번호
- US06127390
반응 노트
불러오는 중…